• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Chiltern wins in 2016 CRO Leadership Awards

Chiltern wins in 2016 CRO Leadership Awards

April 11, 2016
CenterWatch Staff

Chiltern, a global CRO, has been recognized for its excellence in clinical research by Life Science Leader’s 2016 CRO Leaderships Awards. For the fifth straight year, Chiltern was honored in all five core categories: Capabilities, Compatibility, Expertise, Quality and Reliability.

“We are proud to be recognized again by our peers as one of the top CROs in the industry,” said Jim Esinhart, Ph.D., Chiltern CEO. “Chiltern is the only CRO to be awarded in all five overall categories five years in a row. This is a testament to our commitment to building strong collaborative partnerships and striving for clinical excellence. We hope our continued accreditation for top-level performance provides our clients with a high level of confidence going forward.”

The CRO Leadership Awards are presented annually by Life Science Leader, with winners chosen based on research conducted by Industry Standard Research. The results are based on the evaluation of 65 CROs for 27 different performance metrics. Compared to other awards that are based on subjective voting processes, the CRO Leadership Awards ensures that quality ratings come from companies that have worked with the CRO within the last 18 months and that results are backed by experiential data.

In addition to the five overall awards, Chiltern received six additional awards for outstanding service in the Small Pharma and Big Pharma categories. 

Upcoming Events

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • TechInnovation-360x240.png

    Pace of Technology Innovation in Trials Could Slow After Pandemic Eases

  • AskTheExperts-360x240.png

    Ask the Experts: Certifying and Maintaining Copies of Original Source Documents

  • Resources-360x240.png

    Trial Complexity, Endpoints Continue to Increase, Stretching Site Resources

  • FocusinRed-360x240.png

    Return to Focus on Risk Management Postpandemic Could Prove Challenging to Sites

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing